Dianthus Therapeutics
The Director, Clinical Quality Assurance will provide end-to-end quality oversight of global clinical trials to ensure compliance with regulatory requirements and internal standards. The role involves collaborating with cross-functional teams to ensure data integrity, sponsor oversight, and inspection readiness.
Dianthus Therapeutics is a biotechnology company focused on developing next‑generation antibody therapeutics that target the complement system to address diseases with high unmet medical need. The company engineers selective, potent complement‑modulating antibodies with the goal of improving safety and efficacy over existing therapies. Dianthus advances novel antibody candidates toward clinical development and is committed to translating complement biology into meaningful treatments for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dianthus Therapeutics.
Dianthus Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Truist Financial Forecasts Strong Price Appreciation for Dianthus Therapeutics (NASDAQ:DNTH) Stock
2 hours ago
Clinical Quality Assurance Lead
Denali Therapeutics
Senior Quality Assurance and Control Associate - Clinical Research
Baylor College of Medicine
Specialist, Quality Assurance GCP
Alfasigma
(Sr.) Manager, GCP Quality Assurance
Aurabiosciences
Clinical Research Associate/Senior Clinical Research Associate
Septerna
Manager-Clinical Quality & Process
Sun Pharmaceutical Industries Limited